Trials / Completed
CompletedNCT03475784
Two Fluid Strategies for Prevention of Post-dural Puncture Headache
Comparison of Two Fluid Strategies for Prevention of Post-dural Puncture Headache After Cesarean Delivery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Postdural puncture headache (PDPH) is a common complication after cesarean delivery (CD). The role of peri-operative fluid therapy in prophylaxis against PDPH is unclear. The aim of this work is to compare restrictive versus liberal fluid therapy in prophylaxis against PDPH after CD
Detailed description
In this study, the investigators will compare restrictive fluid therapy and liberal fluid therapy in prophylaxis against postdural puncture headache. The restrictive group will not receive preoperative fluid loading, and will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 2 mL/Kg/hour for hours. The Liberal group will receive preoperative fluid loading of 5 mL/Kg, and will receive intraoperative crystalloids at rate of 10 mL/Kg/hour, followed by postoperative crystalloids at rate of 6 mL/Kg/hour. Both groups will be compared regarding demographic data, total peri-operative fluids, incidence of postdural puncture headache, nausea, vomiting, and intraoperative hemodynamics (heart rate and systolic blood pressure) in addition to neonatal outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Restrictive fluid therapy | This group will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 2 mL/Kg/hour. |
| DRUG | Liberal fluid therapy | This group will receive crystalloid preload of 5 mL/Kg, then will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 6 mL/Kg/hour. |
Timeline
- Start date
- 2018-03-30
- Primary completion
- 2018-10-30
- Completion
- 2018-11-02
- First posted
- 2018-03-23
- Last updated
- 2019-08-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03475784. Inclusion in this directory is not an endorsement.